Alzheimer’s Dementia: The Hippo in the Room
-
Register
- User - $10
Alzheimer’s disease is the most common cause of dementia. The etiology is unknown and there is no known cure for this devastating progressive neurodegenerative disease. The hippocampus is affected and prevents the patient from forming new memories. The patient often recognizes it but doesn’t want to talk about the “hippo” in the room. With more than 6 million American’s living with Alzheimer’s disease and a projected doubling of that number, nurse practitioners should be knowledgeable about the disease.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 contact hours; 0.33 are pharmacology
Expiration Date: December 31, 2025
$10.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Be able to demonstrate knowledge of Alzheimer’s Disease
-Be able to develop a diagnosis and treatment plan.
-Discuss the treatment of AD
Kathy Baldridge, DNP, APRN, FNP-BC, FAANP, FAIPM
Director of psychometric analysis , Family nurse practitioner
Advanced Practice Education Associates
Kathy Baldridge is a family nurse practitioner in Pineville, La. She is the director of psychometric analysis at Advanced Practice Education Associates, a nurse practitioner education company. She is a goal directed, results-oriented professional with a strong clinical background and education. Dr. Baldridge is the author of Coding & Billing in the Outpatient Clinical Setting: A quick guide and has authored and coauthored multiple journal articles and book chapters, including content in the 3rd and 4th editions of Clinical Practice Guidelines in Primary Care. In addition, she has served as an editorial reviewer for the Journal of the American Association of Nurse Practitioners (JAANP) for more than 4 years. She has presented numerous lectures and courses at the local, state, and national level. Dedicated to the advancement of Nurse Practitioners, she has served on the Louisiana Association of Nurse Practitioners board of directors in various positions and is currently the president of the association.
She earned her ADN from Louisiana State University, Alexandria in 1993; her BSN (2006) and MSN (2009) from Northwestern State University, Natchitoches, LA; and her DNP from the University of Alabama, Tuscaloosa in 2013. Dr. Baldridge is the recipient of the AANP Award for Excellence and was inducted as a Fellow in the American Association of Nurse Practitioners in 2017. Passionate about caring for others, Dr. Baldridge remains in clinical practice serving the Central Louisiana area.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.33 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Kathy Baldridge, DNP, FNP-BC, FAANP have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
This session is supported by an educational grant from Genentech, a member of the Roche Group.
Key:
Complete
Next
Failed
Available
Locked
